CHAIR
:
SPEAKER
(S):
John McCamant, Editor, Medical Technology Stock Letter
Matthew Geller, Head of Healthcare Investment Banking Senior Managing Director, Investment Banking, Rodman & Renshaw, LLC
Russell Skibsted, Senior Vice President and Chief Business Officer, Spectrum Pharmaceuticals
Description
Many small biotechnology companies find it challenging to attract the attention of investors, potential pharmaceutical partners and media. This panel will delve into some strategies for raising your visibility with investors, potential pharmaceutical partners and media.
Objectives:
Discuss strategies that biotech executives may employ for raising visibility in the investment or pharmaceutical industry.
Educate the audience on the use of various communications activities such as pitching around milestones, employing scientific advisers, using conference calls and Web casts, attending medical meetings and leveraging research and banking contacts to increase a firm's visibility among its target audiences.